2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989. 被引量：1
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946. 被引量：1
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012. 被引量：1
6Cydulka R,Davison R,Grammer L,et al.The use of epinephrine in the treatment of older adult asthmatics[J].Ann EmergMed,1988,17(4):322 -326. 被引量：1
7Spiteri MA,Millar AB,Pavia D,et al.Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma[J].Thorax,1988,43(1):19 -23. 被引量：1
8Smith D,Riel J,Tilles I,et al.Intravenous epinephrine in life threatening asthma[J].Ann Emerg Med,2003,41 (5):706-711. 被引量：1
